HERON THERAPEUTICS, INC.
HRTX · NASDAQ
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
Market Data
Price
$0.99
-0.01 (-0.83%)
Market Cap$193M
P/E Ratio—
EPS$—
52W High$2.61
52W Low$0.91
Beta1.31
Data from Finnhub · Updated Mar 11, 2026